CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c
March 8, 2022 4:17 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... MoreCumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c
March 8, 2022 4:17 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More


